Brenton Saunders - Allergan Plc Chairman

AGN -- USA Stock  

  Buyout Trend

Mr. Brenton L. Saunders is Chairman of the Board, President, Chief Executive Officer of the Company. Mr. Saunders is Chairman, President and Chief Executive Officer of Allergan and has served in the role of President and Chief Executive Officer since July 2014 and of Chairman since October 2016, having previously served as Chief Executive Officer and President of Forest Laboratories, Inc., and as a director of Forest, prior to its acquisition by Allergan . Prior to that, he served as Chief Executive Officer of Bausch Lomb Incorporated, a leading global eye health company, serving in this capacity from March 2010 until August 2013. Mr. Saunders also held a number of leadership positions at ScheringPlough, including the position of President of Global Consumer Health Care and was named head of integration for the companys merger with Merck Co. and for ScheringPloughs acquisition of Organon BioSciences. Before joining ScheringPlough, Mr. Saunders was a Partner and Head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, he was Chief Risk Officer at Coventry Health Care and Senior Vice President, Compliance, Legal and Regulatory at Home Care Corporationrationration of America. Mr. Saunders began his career as Chief Compliance Officer for the Thomas Jefferson University Health System
Age: 48  Chairman Since 2016      
862 261 7000
Saunders serves on the Board of Directors of Cisco Systems, Inc. and RWJBarnabas Health, and is a member of the Business Council and PhRMA.

Management Efficiency

The company has 23.24 B in debt with debt to equity (D/E) ratio of 38.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. Allergan Plc has Current Ratio of 1.01 demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due.

Similar Executives

Found 11 records


Philip HagermanDiplomat Pharmacy
Felix TheeuwesDURECT Corporation
Brian GriffinDiplomat Pharmacy
David HooverElanco Animal Health Incorporat
David PernockFibrocell Science
Roger KimmelEndo International Plc
Richard GlickmanESSA Pharma
Patrick MahaffyFlexion Therapeutics
Vikram MalikEvolus Inc Common Stock
Jay MoorinEagle Pharmaceuticals
Cam GarnerEvoke Pharma

Entity Summary

Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland. Allergan Plc operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 16900 people.Allergan Plc (AGN) is traded on BATS Exchange in USA. It is located in Clonshaugh Business and Technology Park and employs 16,900 people. Allergan Plc is listed under Pharmaceutical Products category by Fama And French industry classification.

Allergan Plc Leadership Team

Matthew Walsh, Chief Financial Officer, Executive Vice President
Robert Bailey, Chief Legal Officer and Corporate Secretary
Robert Stewart, Executive VP and President of Generic and Global Operations
Ronald Taylor, Independent Director
Adriane Brown, Independent Director
William Meury, Executive Vice President, Chief Commercial Officer
Brenton Saunders, Chairman of the Board, President, Chief Executive Officer
Wayne Swanton, Executive Vice President - Global Operations
Robert Hugin, Independent Director
Nicholson, Chief R&D Officer
Christopher Bodine, Independent Director
Karen Ling, Chief Human Resource Officer, Executive Vice President
Michael Gallagher, Lead Independent Director
Paul Bisaro, Executive Chairman
Thomas Freyman, Independent Director
Catherine Klema, Lead Independent Director
James DArecca, Chief Accounting Officer
Christopher Coughlin, Lead Independent Director
Nesli Basgoz, Independent Director
Philippe Schaison, Executive Vice President and President Allergan Medical
Maria Hilado, CFO and Executive VP
Joseph Boccuzi, Independent Director
Patrick OSullivan, Independent Director
Fred Weiss, Independent Director
A Bailey, Executive Vice President, Chief Legal Officer and Corporate Secretary
Alex Kelly, Chief Communications Officer
CDavid Nicholson, Executive Vice President, Chief R&D Officer
Carol Davidson, Independent Director
Michael Greenberg, Independent Director
Ron Taylor, Independent Director
Jonathon Kellerman, Executive Vice President Chief Compliance Officer
Paul Navarre, Executive Vice President and President International Brands
James Bloem, Independent Director
Karina Calzadilla, IR Contact Officer
Peter McDonnell, Independent Director

Stock Performance Indicators

Did you try this?

Run Idea Analyzer Now


Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Allergan Plc Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Allergan Plc and ESSA Pharma. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.